Beverly Tanabe

Beverly (Bev) Tanabe is a dedicated and results-driven executive currently serving as the Chief Revenue Officer at bioXcellerator, where they lead growth strategies in the field of stem cell therapy and regenerative medicine. With over 15 years of experience, they have held key leadership positions in organizations such as Genomind and Centene Corporation, focusing on commercialization strategy and market expansion. Bev has a proven track record in driving revenue generation, establishing strategic partnerships, and leading teams to meet financial goals. They are pursuing a Master of Business Administration (MBA) at the University of San Francisco.